Skip to main content
SpringerLink
Log in

Chemotherapie beim Prostatakarzinom

  • Conference paper
Zytostatische Therapie urologischer Tumoren

Part of the book series: Fortschritte der Urologie und Nephrologie ((2824,volume 24))

  • 19 Accesses

Zusammenfassung

Mehr als 80% der Patienten mit einem Prostatakarzinom weisen zum Zeitpunkt der Diagnose Lymphknoten oder Fernmetastasen auf.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 49.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Babayan RK, De Vere White R, Olsson CA (1981) Ajuvant chemotherapy for stage D1 Prostate Cancer. Lecture held at the Meeting of the American Urological Association, Boston

    Google Scholar 

  • Catalona WJ (1985) Prostate Cancer. Grüne & Stratton, New York

    Google Scholar 

  • Edsmyr F, Andersson L, Könyver J (1982) Estramustinephosphat. Experimental studies and clinical experience. In: Jacobi GH, Hohenfellner R (eds) Prostata Cancer. Williams & Wilkins, B altimore-London

    Google Scholar 

  • Isaacs JT (1984) The timing of androgen ablation therapy and/or chemotherapy in the treatment of prostatic cancer. Prostate 5: 1–17

    Article  PubMed  CAS  Google Scholar 

  • Murphy GP, Slack NH and participants in the NPCP (1984) Treatment Protocol. Current status of the National Prostatic Cancer Project; Treatment Protocols. Controlled Clinical Trials in Urologie Oncology. Vol 13. In: Denis L, Murphy GP, Prout GR, Schröder F (eds) Raven Press, New York

    Google Scholar 

  • Scott WW,Gibbons RP, Johnson DE, Prout GR, Schmidt JD, Saroff J, Murphy GP (1976) The continued evaluation of the effects of chemotherapy in patients with advanced Carcinoma of the prostate. J Urol 116: 211

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Urologische Abteilung des Stadtkrankenhauses Memmingen, Deutschland

    Prof. Dr. P. Faul (Chefarzt) & H. Rübben

  2. Urologische Abteilung der Medizinischen Fakultät an der RWTH Aachen, Deutschland

    Prof. Dr. P. Faul (Chefarzt) & H. Rübben

Authors
  1. Prof. Dr. P. Faul
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. H. Rübben
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

O. Hallwachs

Rights and permissions

Reprints and permissions

Copyright information

© 1986 Dr. Dietrich Steinkopff Verlag, GmbH & Co. KG., Darmstadt

About this paper

Cite this paper

Faul, P., Rübben, H. (1986). Chemotherapie beim Prostatakarzinom. In: Hallwachs, O. (eds) Zytostatische Therapie urologischer Tumoren. Fortschritte der Urologie und Nephrologie, vol 24. Steinkopff. https://doi.org/10.1007/978-3-642-72398-8_4

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-72398-8_4

  • Publisher Name: Steinkopff

  • Print ISBN: 978-3-7985-0709-8

  • Online ISBN: 978-3-642-72398-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation